Egyptian businesswoman Hend El-Sherbini’s IDH posts $51.4-million revenue in H1 2024
IDH's core markets of Egypt and Jordan demonstrated strong performance, highlighting resilience despite regional challenges.
IDH's core markets of Egypt and Jordan demonstrated strong performance, highlighting resilience despite regional challenges.
El-Sherbini added that IDH’s core markets of Egypt and Jordan displayed strong growth, indicating further potential.
El-Sherbini owns a significant 26.71-percent stake in IDH — this translates to 160,250,305 ordinary shares in the company.
El-Sherbini remains one of Egypt’s richest businesswomen and one of the top investors on the Egyptian Stock Exchange.
Billionaires.Africa has identified and cataloged various companies and holdings linked to El-Sherbini.
El-Sherbini owns a significant 26.71-percent stake in the company, or 160,250,305 ordinary shares.
El-Sherbini owns a significant 25.5-percent stake in Integrated Diagnostics Holdings.
El-Sherbini owns a significant 25.5-percent stake in Integrated Diagnostics Holdings.
Integrated Diagnostics Holdings is a renowned healthcare services provider.
IDH is a major consumer healthcare group in the Middle East and Africa.
El-Sherbini explained that the ramp-up strategy will create added value for IDH.
El-Sherbini controls a 26.1-percent stake in the group.
El-Sherbini controls a significant 26.1-percent stake in Integrated Diagnostics Holdings.
However, Oppenheimer’s net worth has risen by $750 million since the start of the year.
His net worth has risen by more than $675 million since the year began.
This is a quarter of the $70-million dividend approved by the board at the end of the 2021 financial year.